Skip to main content

Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer

Publication ,  Conference
Zighelboim, I; Wright, JD; Gao, F; Case, AS; Massad, LS; Mutch, DG; Powell, MA; Thaker, PH; Eisenhauer, EL; Cohn, DE; Valea, FA; Secord, AA ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2012

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2012

Volume

30

Issue

15

Location

Chicago, IL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zighelboim, I., Wright, J. D., Gao, F., Case, A. S., Massad, L. S., Mutch, D. G., … Rader, J. S. (2012). Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 30). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
Zighelboim, Israel, Jason D. Wright, Feng Gao, Ashley Stephens Case, L Stewart Massad, David Gardner Mutch, Matthew A. Powell, et al. “Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, et al. Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.
Zighelboim, Israel, et al. “Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 15, AMER SOC CLINICAL ONCOLOGY, 2012.
Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Secord AA, Lippmann LT, Rader JS. Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2012

Volume

30

Issue

15

Location

Chicago, IL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences